ColgatePalmolive (CL)
(Delayed Data from NYSE)
$90.77 USD
+0.55 (0.61%)
Updated Nov 7, 2024 03:59 PM ET
After-Market: $90.75 -0.02 (-0.02%) 6:38 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$90.77 USD
+0.55 (0.61%)
Updated Nov 7, 2024 03:59 PM ET
After-Market: $90.75 -0.02 (-0.02%) 6:38 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Zacks News
Is Church & Dwight Co. (CHD) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Here is how Church & Dwight (CHD) and Colgate-Palmolive (CL) have performed compared to their sector so far this year.
Newell (NWL) Q4 Earnings Surpass Estimates, Sales Down Y/Y
by Zacks Equity Research
Newell's (NWL) fourth-quarter 2023 sales decline 9.1% year over year on lower core sales and impacts of category exits.
These 2 Consumer Staples Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Hain Celestial (HAIN) Q2 Earnings Beat Estimates, Decline Y/Y
by Zacks Equity Research
Hain Celestial (HAIN) posts mixed results in second-quarter fiscal 2024. The International segment's net sales grew 8.5% year over year in the quarter.
The Zacks Analyst Blog Highlights Meta Platforms, Eaton, The Cigna, Colgate-Palmolive and Parker-Hannifin
by Zacks Equity Research
Meta Platforms, Eaton, The Cigna, Colgate-Palmolive and Parker-Hannifin are included in this Analyst Blog.
Top Analyst Reports for Meta Platforms, Eaton & Cigna
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), Eaton Corporation plc (ETN) and The Cigna Group (CI).
Clorox (CLX) Q2 Earnings & Revenues Beat Estimates, Rise Y/Y
by Zacks Equity Research
Clorox (CLX) posts solid second-quarter fiscal 2024 results, backed by higher volumes, and gains from pricing actions and cost-saving initiatives.
4 Best-Performing ETF Areas of Last Week
by Sanghamitra Saha
Wall Street was upbeat last week.
Zacks Investment Ideas feature highlights: Booz Allen Hamilton, ColgatePalmolive and Gentex
by Zacks Equity Research
Booz Allen Hamilton, ColgatePalmolive and Gentex are part of the Zacks Investment Ideas article.
3 Standout Stocks to Buy After Earnings
by Shaun Pruitt
Booz Allen Hamilton (BAH), Colgate-Palmolive (CL), and Gentex (GNTX) have started to reconfirm their growth expectations after strong quarterly results.
Why Colgate-Palmolive (CL) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Colgate-Palmolive (CL) have what it takes? Let's find out.
Company News for Jan 29, 2024
by Zacks Equity Research
Companies in The News Are: CL,NSCALV,BAH
Colgate-Palmolive Company (CL) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Colgate-Palmolive (CL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Best Inverse/Leveraged ETFs of Last Week
by Sanghamitra Saha
Wall Street was upbeat last week.
Colgate (CL) Q4 Earnings & Sales Beat Estimates, '24 View Issued
by Zacks Equity Research
Colgate's (CL) Q4 results benefited from strong sales growth, robust organic volume growth and gross and operating margin expansion.
Is ColgatePalmolive (CL) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Here is how Colgate-Palmolive (CL) and Kerry Group PLC (KRYAY) have performed compared to their sector so far this year.
Colgate-Palmolive (CL) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Colgate-Palmolive (CL) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Colgate-Palmolive (CL) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Colgate-Palmolive (CL) delivered earnings and revenue surprises of 2.35% and 1.06%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Here's How Clorox (CLX) is Placed Just Ahead of Q2 Earnings
by Zacks Equity Research
Clorox's (CLX) Q2 results are expected to reflect gains from solid demand, cost-saving efforts, strong execution and pricing actions. Its IGNITE strategy and digital investments bode well.
3 Reasons Why Growth Investors Shouldn't Overlook Colgate-Palmolive (CL)
by Zacks Equity Research
Colgate-Palmolive (CL) could produce exceptional returns because of its solid growth attributes.
The Zacks Analyst Blog Highlights Alphabet, Salesforce, Comcast, Colgate-Palmolive and American Water Works
by Zacks Equity Research
Alphabet, Salesforce, Comcast, Colgate-Palmolive and American Water Works are included in this Analyst Blog.
Colgate-Palmolive (CL) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
by Zacks Equity Research
Get a deeper insight into the potential performance of Colgate-Palmolive (CL) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Procter & Gamble (PG) Beats Q2 Earnings Estimates, Ups EPS View
by Zacks Equity Research
Procter & Gamble's (PG) Q2 results reflect robust pricing, along with growth across all segments. All its business segments have seen growth in organic sales.
The Zacks Analyst Blog Highlights Alphabet, Salesforce, Comcast, Colgate-Palmolive and American Water Works
by Zacks Equity Research
Alphabet, Salesforce, Comcast, Colgate-Palmolive and American Water Works are part of the Zacks top Analyst Blog.
Colgate (CL) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Colgate's (CL) fourth-quarter 2023 performance is likely to have gained from solid consumer demand and efforts related to innovation, premiumization and digital transformation.